|
[1]
|
Nichols, M., Townsend, N., Scarborough, P. and Rayner, M. (2014) Cardiovascular Disease in Europe 2014: Epidemiological Update. European Heart Journal, 35, 2950-2959. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Benjamin, E.J., et al. (2018) Heart Disease and Stroke Statistics—2018 Update: A Report from the American Heart Association. Circulation, 137, e467-e492. [Google Scholar] [CrossRef]
|
|
[3]
|
Reed, G.W., Rossi, J.E. and Cannon, C.P. (2017) Acute Myocardial Infarction. The Lancet, 389, 197-210. [Google Scholar] [CrossRef]
|
|
[4]
|
Thygesen, K., et al. (2012) Third Universal Definition of Myocardial Infarction. European Heart Journal, 33, 2551-2567. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Thygesen, K., et al. (2018) Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology, 72, 2231-2264. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Shen, C. and Ge, J. (2018) Epidemic of Cardiovascular Disease in China: Current Perspective and Prospects for the Future. Circulation, 138, 342-344. [Google Scholar] [CrossRef]
|
|
[7]
|
Granger, C.B., et al. (2003) Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Archives of Internal Medicine, 163, 2345-2353. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Lin, A., Devlin, G., Lee, M. and Kerr, A.J. (2014) Performance of the GRACE Scores in a New Zealand Acute Coronary Syndrome Cohort. Heart, 100, 1960-1966. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Shuvy, M., et al. (2018) Accuracy of the Global Registry of Acute Coronary Events (GRACE) Risk Score in Contemporary Treatment of Patients with Acute Coronary Syndrome. The Canadian Journal of Cardiology, 34, 1613-1617. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Morrow, D.A., et al. (2000) TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarction Myocardium Early II Trial Substudy. Circulation, 102, 2031-2037. [Google Scholar] [CrossRef]
|
|
[11]
|
Antman, E.M., et al. (2000) The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI: A Method for Prognostication and Therapeutic Decision Making. JAMA, 284, 835-842. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Morrow, D.A., et al. (2001) Application of the TIMI Risk Score for ST-Elevation MI in the National Registry of Myocardial Infarction 3. JAMA, 286, 1356-1359. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Bradshaw, P.J., et al. (2007) Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Index for Predicting Early Mortality in a Population-Based Cohort of STEMI and Non-STEMI Patients. The Canadian Journal of Cardiology, 23, 51-56. [Google Scholar] [CrossRef]
|
|
[14]
|
Bibbins-Domingo, K., Ansari, M., Schiller, N.B., Massie, B. and Whooley, M.A. (2003) B-Type Natriuretic Peptide and Ischemia in Patients with Stable Coronary Disease: Data from the Heart and Soul Study. Circulation, 108, 2987-2992. [Google Scholar] [CrossRef]
|
|
[15]
|
Kragelund, C., et al. (2005) N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease. The New England Journal of Medicine, 352, 666-675. [Google Scholar] [CrossRef]
|
|
[16]
|
Gong, P., et al. (2016) Plasma D-Dimer as a Useful Marker Predicts Severity of Atherosclerotic Lesion and Short-Term Outcome in Patients with Coronary Artery Disease. Clinical and Applied Thrombosis/Hemostasis, 22, 633-640. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Tataru, M.C., Heinrich, J., Junker, R., Schulte, H., von Eckardstein, A., Assmann, G. and Koehler, E. (1999) D-Dimers in Relation to the Severity of Arteriosclerosis in Patients with Stable Angina Pectoris after Myocardial Infarction. European Heart Journal, 20, 1493-1502. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Kikkert, W.J., et al. (2014) D-Dimer Levels Predict Ischemic and Hemorrhagic Outcomes after Acute Myocardial Infarction: A HORIZONS-AMI Biomarker Substudy. Journal of Thrombosis and Thrombolysis, 37, 155-164. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Tahhan, A.S., et al. (2018) High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes. Journal of the American Heart Association, 7, e007914. [Google Scholar] [CrossRef]
|
|
[20]
|
Clerico, A., Emdin, M. and Passino, C. (2014) Cardiac Biomarkers and Risk Assessment in Patients Undergoing Major Non-Cardiac Surgery: Time to Revise the Guidelines? Clinical Chemistry and Laboratory Medicine, 52, 959-963. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Omland, T., et al. (2013) Prognostic Value of Cardiac Troponin I Measured with a Highly Sensitive Assay in Patients with Stable Coronary Artery Disease. Journal of the American College of Cardiology, 61, 1240-1249. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Prugger, C., et al. (2013) Multiple Biomarkers for the Prediction of Ischemic Stroke: The PRIME Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 659-666. [Google Scholar] [CrossRef]
|
|
[23]
|
Ibanez, B., et al. (2018) 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation: The Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 39, 119-177. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Roffi, M., et al. (2016) 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 37, 267-315. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Huang, W., et al. (2016) Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death after Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort. American Journal of Cardiology, 118, 1105-1110. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Liu, S., et al. (2019) Burden of Cardiovascular Diseases in China, 1990-2016: Findings from the 2016 Global Burden of Disease Study. JAMA Cardiology, 4, 342-352. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Leong, D.P., et al. (2017) Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease. Circulation Research, 121, 695-710. [Google Scholar] [CrossRef]
|
|
[28]
|
Laslett, L.J., et al. (2012) The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues: A Report from the American College of Cardiology. Journal of the American College of Cardiology, 60, S1-S49. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Chen, Y.H., Huang, S.S. and Lin, S.J. (2018) TIMI and GRACE Risk Scores Predict Both Short-Term and Long-Term Outcomes in Chinese Patients with Acute Myocardial Infarction. Acta Cardiologica Sinica, 34, 4-12.
|
|
[30]
|
Gray, H.H. and Henderson, R.A. (2011) The GRACE Score’s Performance in Predicting In-Hospital and 1-Year Outcome. Heart, 97, 1461-1462. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Ramsay, G., Podogrodzka, M., McClure, C. and Fox, K.A.A. (2007) Risk Prediction in Patients Presenting with Suspected Cardiac Pain: The GRACE and TIMI Risk Scores versus Clinical Evaluation. QJM, 100, 11-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Lowe, G.D., et al. (2004) C-Reactive Protein, Fibrin D-Dimer, and Risk of Ischemic Heart Disease: The Caerphilly and Speedwell Studies. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1957-1962. [Google Scholar] [CrossRef]
|
|
[33]
|
Schiele, F., et al. (2010) C-Reactive Protein Improves Risk Prediction in Patients with Acute Coronary Syndromes. European Heart Journal, 31, 290-297. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Eggers, K.M., et al. (2008) Prevalence and Pathophysiological Mechanisms of Elevated Cardiac Troponin I Levels in a Population-Based Sample of Elderly Subjects. European Heart Journal, 29, 2252-2258. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Khan, S.Q., et al. (2009) N-Terminal Pro-B-Type Natriuretic Peptide Complements the GRACE Risk Score in Predicting Early and Late Mortality Following Acute Coronary Syndrome. Clinical Science (London, England: 1979), 117, 31-39. [Google Scholar] [CrossRef]
|